Resources Archives

December 2, 2024

Increasing Diversity in CLL Clinical Trials

Minority patients are underrepresented in hematology clinical trials, but this is improved by using nontraditional trial sites in other counties.

November 6, 2024

CLL Society Presents ECCO Initiative to Increase Health Equity

At Lymphoma Coalition’s 2024 Global Summit, Fernando Parra Chong presented on CLL Society’s Equitable Community Care Outreach (ECCO) Initiative.

September 23, 2024

How CLL Impacts Different Racial and Ethnic Populations

Regardless of race, when individuals with chronic lymphocytic leukemia (CLL) have equal access to cancer care, overall survival is similar for all patients.

August 16, 2024

Chronic Lymphocytic Leukemia in Adolescents and Young Adults

Though chronic lymphocytic leukemia (CLL) is rare in younger patients, adolescents and young adults with CLL have a better prognosis than older patients.

July 25, 2024

Racial Disparities in CLL Patient Outcomes in the Post-BTKi Era

Ten-year follow-up data showed that lenalidomide plus rituximab produced high response rates in patients with CLL with no significant safety signals.

February 1, 2024

Palliative Care Use Among Hospitalized Lymphoma Patients

Palliative care can be an important part of the treatment approach for leukemia and lymphoma patients, but there are disparities in which patients receive it.

January 26, 2024

Global Disparities in Phase 3 Leukemia Trials

Improving global representation in clinical trials is important for addressing enduring health disparities in underrepresented regions.

January 19, 2024

Racial Disparities in Blood Cancer Survival Outcomes

Access to healthcare contributes to racial and ethnic disparities in survival outcomes for patients with blood cancers such as chronic lymphocytic leukemia.

January 15, 2024

Outcomes for Patients with CLL Vary by Race and Income Level

There continue to be disparities in survival based on race and income level among patients with chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL).

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Resources

Increasing Diversity in CLL Clinical Trials

CLL Society Presents ECCO Initiative to Increase Health Equity

How CLL Impacts Different Racial and Ethnic Populations

Chronic Lymphocytic Leukemia in Adolescents and Young Adults

Racial Disparities in CLL Patient Outcomes in the Post-BTKi Era

Palliative Care Use Among Hospitalized Lymphoma Patients

Global Disparities in Phase 3 Leukemia Trials

Racial Disparities in Blood Cancer Survival Outcomes

Outcomes for Patients with CLL Vary by Race and Income Level

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT